Vunakizumab Combined With Recaticimab in Subjects With Moderate to Severe Plaque Psoriasis and Dyslipidemia

NCT07373847 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: vunakizumab and recaticimab.
DRUG: vunakizumab and placebo

Sponsor

Xiangya Hospital of Central South University